First Time Loading...

Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 432.5 SEK 3.22%
Updated: May 31, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

2.3B
+3%
Assets
Growth Rates:
1 Year
+30%
3 Years
+93%
5 Years
+275%
7 Years
+561%
10 Years
+1 615%
250.5m
+6%
Liabilities
Growth Rates:
1 Year
-14%
3 Years
+71%
5 Years
+327%
7 Years
+894%
10 Years
+657%
2B
+3%
Equity
Growth Rates:
1 Year
+38%
3 Years
+96%
5 Years
+269%
7 Years
+535%
10 Years
+1 938%

Balance Sheet Decomposition
Xvivo Perfusion AB

2.3B
Assets
250.5m
Liabilities
2.3B
Assets
250.5m
Liabilities
Current Assets 830.7m
Cash & Short-Term Investments 511.2m
Receivables 168.6m
Other Current Assets 151m
Non-Current Assets 1.4B
Long-Term Investments 45.2m
PP&E 110.1m
Intangibles 1.3B
Current Liabilities 199.8m
Other Current Liabilities 199.8m
Non-Current Liabilities 50.7m
Long-Term Debt 19.9m
Other Non-Current Liabilities 30.8m

Balance Sheet
Xvivo Perfusion AB

Rotate your device to view
Balance Sheet
Currency: SEK
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
48
41
25
195
187
160
354
399
247
546
Cash Equivalents
48
41
25
195
187
160
354
399
247
546
Short-Term Investments
0
0
0
0
0
0
0
0
71
300
Total Receivables
14
21
29
27
47
49
44
60
100
139
Accounts Receivables
12
20
27
25
44
44
40
52
95
139
Other Receivables
1
1
2
2
3
5
3
8
5
0
Inventory
26
29
35
31
36
44
59
78
107
142
Other Current Assets
5
5
10
11
7
7
6
12
15
28
Total Current Assets
93
96
99
265
278
260
463
548
468
826
PP&E Net
1
7
15
16
16
24
21
26
48
98
PP&E Gross
1
7
15
16
16
24
21
26
48
98
Accumulated Depreciation
1
2
8
12
17
26
37
45
56
70
Intangible Assets
97
93
158
177
214
273
401
465
553
629
Goodwill
4
4
66
65
66
66
224
460
625
591
Long-Term Investments
5
4
0
0
0
0
1
1
0
37
Other Long-Term Assets
0
0
12
15
14
12
40
42
39
51
Other Assets
4
4
66
65
66
66
224
460
625
591
Total Assets
200
N/A
204
+2%
350
+71%
539
+54%
587
+9%
634
+8%
1 150
+81%
1 543
+34%
1 733
+12%
2 181
+26%
Liabilities
Accounts Payable
7
4
13
11
16
14
14
21
38
36
Accrued Liabilities
8
10
18
19
24
33
53
50
56
73
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
3
4
4
6
10
Other Current Liabilities
4
2
0
1
2
2
1
29
35
124
Total Current Liabilities
18
16
31
31
43
53
72
105
135
134
Long-Term Debt
0
0
0
0
0
2
3
2
4
21
Deferred Income Tax
3
3
2
2
2
1
25
25
26
29
Other Liabilities
1
1
1
1
1
1
41
126
138
80
Total Liabilities
22
N/A
19
-10%
34
+74%
34
+2%
46
+35%
57
+23%
142
+149%
257
+81%
303
+18%
236
-22%
Equity
Common Stock
1
1
1
1
1
1
1
1
1
1
Retained Earnings
23
30
35
36
53
61
1
31
116
180
Additional Paid In Capital
155
155
281
468
487
516
1 007
1 253
1 314
1 764
Other Equity
0
0
0
0
0
0
0
0
0
1 945
Total Equity
178
N/A
185
+4%
316
+71%
504
+59%
540
+7%
578
+7%
1 008
+75%
1 285
+27%
1 430
+11%
1 945
+36%
Total Liabilities & Equity
200
N/A
204
+2%
350
+71%
539
+54%
587
+9%
634
+8%
1 150
+81%
1 543
+34%
1 733
+12%
2 181
+26%
Shares Outstanding
Common Shares Outstanding
22
22
24
26
26
27
29
29
30
31

See Also

Summary
XVIVO intrinsic value, competitors valuation, and company profile.
DCF Valuation
XVIVO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XVIVO stock valuation using valuation multiples.
Wall Street Estimates
XVIVO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XVIVO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 142,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.